Your browser doesn't support javascript.
loading
A novel small molecule inhibitor of p38⍺ MAP kinase augments cardiomyocyte cell cycle entry in response to direct cell cycle stimulation.
Abouleisa, Riham R E; Miller, Jessica M; Gebreil, Ahmad; Salama, Abou Bakr M; Dwenger, Marc; Abdelhafez, Hania; Wahid, Reham M; Adewumi, Adeniyi T; Soliman, Mahmoud E S; Abo-Dya, Nader E; Mohamed, Tamer M A.
Affiliation
  • Abouleisa RRE; Institute of Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Miller JM; Institute of Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Gebreil A; Institute of Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Salama ABM; Institute of Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Dwenger M; Department of Cardiovascular Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Abdelhafez H; Institute of Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Wahid RM; Institute of Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Adewumi AT; Institute of Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  • Soliman MES; Physiology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Abo-Dya NE; Molecular Bio-computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Mohamed TMA; Molecular Bio-computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Br J Pharmacol ; 180(24): 3271-3289, 2023 12.
Article in En | MEDLINE | ID: mdl-37547998
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocytes, Cardiac / Enzyme Inhibitors Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Br J Pharmacol Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocytes, Cardiac / Enzyme Inhibitors Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Br J Pharmacol Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom